GWM
ABBV icon

Gilpin Wealth Management’s AbbVie ABBV Stock Holding History

Gilpin Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$234K Buy
893
+380
+74% +$97.4K 0.16% 119
2026
Q2 		$129K Hold
513
– – 0.09% 162
2026
Q1 		$112K Hold
513
– – 0.09% 161
2025
Q4 		$117K Buy
+513
New +$117K 0.09% 146

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Gilpin Wealth Management's ABBV Position: Q3 2026 in Review

Gilpin Wealth Management increased its AbbVie (ABBV) stake by 74% in Q3 2026, buying an estimated $97.4K and bringing the position to 893 shares worth $234K. The position accounts for 0.16% of the portfolio, ranked #119.

Gilpin Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Gilpin Wealth Management held 893 shares of AbbVie worth $234K as of Q3 2026.
  • Gilpin Wealth Management bought 380 AbbVie shares in Q3 2026, an estimated $97.4K.
  • AbbVie made up 0.16% of Gilpin Wealth Management's portfolio in Q3 2026, its #119 holding.
  • Gilpin Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.